skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Humans remover assunto: Treatment Outcome remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Robotic neurorehabilitation: a computational motor learning perspective
Robotic neurorehabilitation: a computational motor learning perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

Robotic neurorehabilitation: a computational motor learning perspective

Huang, Vincent S ; Krakauer, John W

Journal of neuroengineering and rehabilitation, 2009-02, Vol.6 (1), p.5-5, Article 5 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma

Kumar, Shaji ; Flinn, Ian ; Richardson, Paul G. ; Hari, Parameswaran ; Callander, Natalie ; Noga, Stephen J. ; Stewart, A. Keith ; Turturro, Francesco ; Rifkin, Robert ; Wolf, Jeffrey ; Estevam, Jose ; Mulligan, George ; Shi, Hongliang ; Webb, Iain J. ; Rajkumar, S. Vincent

Blood, 2012-05, Vol.119 (19), p.4375-4382 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

Rajkumar, S. Vincent ; Harousseau, Jean-Luc ; Durie, Brian ; Anderson, Kenneth C. ; Dimopoulos, Meletios ; Kyle, Robert ; Blade, Joan ; Richardson, Paul ; Orlowski, Robert ; Siegel, David ; Jagannath, Sundar ; Facon, Thierry ; Avet-Loiseau, Hervé ; Lonial, Sagar ; Palumbo, Antonio ; Zonder, Jeffrey ; Ludwig, Heinz ; Vesole, David ; Sezer, Orhan ; Munshi, Nikhil C. ; San Miguel, Jesus

Blood, 2011-05, Vol.117 (18), p.4691-4695 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

Stewart, A. Keith ; Rajkumar, S. Vincent ; Dimopoulos, Meletios A ; Masszi, Tamás ; Špička, Ivan ; Oriol, Albert ; Hájek, Roman ; Rosiñol, Laura ; Siegel, David S ; Mihaylov, Georgi G ; Goranova-Marinova, Vesselina ; Rajnics, Péter ; Suvorov, Aleksandr ; Niesvizky, Ruben ; Jakubowiak, Andrzej J ; San-Miguel, Jesus F ; Ludwig, Heinz ; Wang, Michael ; Maisnar, Vladimír ; Minarik, Jiri ; Bensinger, William I ; Mateos, Maria-Victoria ; Ben-Yehuda, Dina ; Kukreti, Vishal ; Zojwalla, Naseem ; Tonda, Margaret E ; Yang, Xinqun ; Xing, Biao ; Moreau, Philippe ; Palumbo, Antonio

The New England journal of medicine, 2015-01, Vol.372 (2), p.142-152 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
5
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Rajkumar, S Vincent, Prof ; Jacobus, Susanna, MS ; Callander, Natalie S, MD ; Fonseca, Rafael, Prof ; Vesole, David H, Prof ; Williams, Michael E, Prof ; Abonour, Rafat, MD ; Siegel, David S, Prof ; Katz, Michael, BS ; Greipp, Philip R, Prof

The lancet oncology, 2010-01, Vol.11 (1), p.29-37 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma

Bergsagel, P. Leif ; Mateos, María-Victoria ; Gutierrez, Norma C. ; Rajkumar, S. Vincent ; San Miguel, Jesús F.

Blood, 2013-02, Vol.121 (6), p.884-892 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Treatment of Myeloma: Cure vs Control
Treatment of Myeloma: Cure vs Control
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of Myeloma: Cure vs Control

Rajkumar, S. Vincent, MD

Mayo Clinic proceedings, 2008-10, Vol.83 (10), p.1142-1145 [Periódico revisado por pares]

England: Elsevier, Inc

Texto completo disponível

Citações Citado por
8
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits

Zand, Ladan ; Rajkumar, S Vincent ; Leung, Nelson ; Sethi, Sanjeev ; El Ters, Mireille ; Fervenza, Fernando C

Journal of the American Society of Nephrology, 2021-05, Vol.32 (5), p.1163-1173 [Periódico revisado por pares]

United States: American Society of Nephrology

Texto completo disponível

Citações Citado por
9
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

Durie, Brian G M ; Hoering, Antje ; Sexton, Rachael ; Abidi, Muneer H ; Epstein, Joshua ; Rajkumar, S Vincent ; Dispenzieri, Angela ; Kahanic, Stephen P ; Thakuri, Mohan C ; Reu, Frederic J ; Reynolds, Christopher M ; Orlowski, Robert Z ; Barlogie, Bart

Blood cancer journal (New York), 2020-05, Vol.10 (5), p.53-53, Article 53 [Periódico revisado por pares]

United States: Springer Nature B.V

Texto completo disponível

Citações Citado por
10
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial

Kumar, Shaji K ; Jacobus, Susanna J ; Cohen, Adam D ; Weiss, Matthias ; Callander, Natalie ; Singh, Avina K ; Parker, Terri L ; Menter, Alexander ; Yang, Xuezhong ; Parsons, Benjamin ; Kumar, Pankaj ; Kapoor, Prashant ; Rosenberg, Aaron ; Zonder, Jeffrey A ; Faber, Edward ; Lonial, Sagar ; Anderson, Kenneth C ; Richardson, Paul G ; Orlowski, Robert Z ; Wagner, Lynne I ; Rajkumar, S Vincent

The lancet oncology, 2020-10, Vol.21 (10), p.1317-1330 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (5.171)
  2. Revistas revisadas por pares (5.230)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (5.527)
  2. magazinearticle  (8)
  3. Web Resources  (4)
  4. Anais de Congresso  (2)
  5. Book Chapters  (1)
  6. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (70)
  2. 1996Até2002  (344)
  3. 2003Até2009  (1.003)
  4. 2010Até2017  (2.497)
  5. Após 2017  (1.629)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (5.477)
  2. Japonês  (689)
  3. Francês  (67)
  4. Holandês  (8)
  5. Alemão  (6)
  6. Português  (5)
  7. Chinês  (4)
  8. Russo  (3)
  9. Norueguês  (2)
  10. Italiano  (1)
  11. Espanhol  (1)
  12. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.